NewsBenzingaMorgan Stanley Maintains Equal-Weight on Amgen, Lowers Price Target to $359 Morgan Stanley Maintains Equal-Weight on Amgen, Lowers Price Target to $359 Benzinga 2026.10.07 14:22 (GMT+0) Open on Benzinga Other news Meta rolls out new AI tools to detect ads that secretly lead to child sexual abuse material CoreWeave Bets on India With 240MW AI Project - TipRanks.com Apple, IBD Stock Of The Day, Rises Near Buy Points Ahead Of Smart Home Launch Wells Fargo Maintains Equal-Weight on Expedia Group, Lowers Price Target to $275 Wells Fargo Maintains Equal-Weight on Booking Holdings, Lowers Price Target to $190 Uber Technologies: Delivery Hero, ezCater Acquisition Should Push 2027 Bookings To Over $340B
